Imipenem cilastatin labels and packages: Difference between revisions

Jump to navigation Jump to search
ShiSheng (talk | contribs)
Created page with "__NOTOC__ {{imipenem cilastatin}} {{CMG}} ==Labels and Packages== {| |- |[[|thumb|400px|left]] |- |} {| |- |[[|thumb|400px|left]] |- |} {| |- |[[|thumb|400px|left]] |- |} ..."
 
ShiSheng (talk | contribs)
Line 7: Line 7:
{|
{|
|-
|-
|[[|thumb|400px|left]]
|[[File:Imipenem Cilastatin 8.jpg|thumb|400px|left]]
|-
|-
|}
|}
Line 13: Line 13:
{|
{|
|-
|-
|[[|thumb|400px|left]]
|[[File:Imipenem Cilastatin 9.jpg|thumb|400px|left]]
|-
|-
|}
|}
Line 19: Line 19:
{|
{|
|-
|-
|[[|thumb|400px|left]]
|[[File:Imipenem Cilastatin 10.jpg|thumb|400px|left]]
|-
|-
|}
|}
Line 25: Line 25:
{|
{|
|-
|-
|[[|thumb|400px|left]]
|[[File:Imipenem Cilastatin 11.jpg|thumb|400px|left]]
|-
|-
|}<ref>{{Cite web | last = | first = |title =http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050587s065,050630s028lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050587s065,050630s028lbl.pdf | publisher =|date = | accessdate = }}</ref>
|}<ref>{{Cite web | last = | first = |title =http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050587s065,050630s028lbl.pdf | url =http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050587s065,050630s028lbl.pdf | publisher =|date = | accessdate = }}</ref>

Revision as of 21:33, 26 December 2013

Imipenem Cilastatin
PRIMAXIN® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
Compatibility, Reconstitution, and Stability
Directions For Use
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Labels and Packages

thumb|400px|left
thumb|400px|left
thumb|400px|left
thumb|400px|left

[1]

References

  1. "http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050587s065,050630s028lbl.pdf" (PDF). External link in |title= (help)

Adapted from the FDA Package Insert.